|
BMS and Sanofi-Aventis Hypertension Drug Approved for Additional Use
The FDA has approved sanofi-aventis and Bristol-Myers Squibb’s (BMS) supplemental new drug application for initial use of their antihypertensive drug Avalide in patients with hypertension who are likely to need multiple drugs to lower their blood pressure.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives